CA2264277A1 - Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer - Google Patents

Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer

Info

Publication number
CA2264277A1
CA2264277A1 CA002264277A CA2264277A CA2264277A1 CA 2264277 A1 CA2264277 A1 CA 2264277A1 CA 002264277 A CA002264277 A CA 002264277A CA 2264277 A CA2264277 A CA 2264277A CA 2264277 A1 CA2264277 A1 CA 2264277A1
Authority
CA
Canada
Prior art keywords
mammary fluid
methods
kits
breast
mammary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002264277A
Other languages
French (fr)
Other versions
CA2264277C (en
Inventor
Steven C. Quay
Debra Quay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atossa Therapeutics Inc
Original Assignee
Steven C. Quay
Debra Quay
K-Quay Enterprises, Llc
Atossa Healthcare, Inc.
Nastech Pharmaceutical Company Inc.
Mdrna, Inc.
Atossa Genetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steven C. Quay, Debra Quay, K-Quay Enterprises, Llc, Atossa Healthcare, Inc., Nastech Pharmaceutical Company Inc., Mdrna, Inc., Atossa Genetics filed Critical Steven C. Quay
Publication of CA2264277A1 publication Critical patent/CA2264277A1/en
Application granted granted Critical
Publication of CA2264277C publication Critical patent/CA2264277C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Abstract

Non-invasive methods and kits are provided for obtaining biological samples of mammary fluid or mammary fluid components by administering oxytocin or an oxytocin analogue to a mammalian patient to stimulate expression of mammary fluid. The oxytocin is preferably administered intranasally and causes myoepithelial contraction of target alveolar-ductal tissues of the breast. During or after mammary fluid expression, a biological sample is collected in the form of whole mammary fluid, whole cells or cellular components, other selected liquid or solid fractions of the mammary fluid, purified or bulk proteins, glycoproteins, peptides, nucleotides or other desired constituents of mammary fluid. Methods and kits are also provided for determining the presence or amount of a breast disease marker in biological samples of mammary fluid or mammary fluid components. Samples obtained according to the above sample collection methods are assayed to determine the presence and/or amount of a breast disease marker, for example a breast cancer marker such as CEA, HMFG, MCA, vasopressin, or cathepsin D, in the sample. Cellular samples obtained according to the above sample collection methods are also examined microscopically for cytological evidence of breast disease.
CA002264277A 1996-08-27 1997-08-22 Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer Expired - Fee Related CA2264277C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/709,207 1996-08-27
US08/709,207 US5798266A (en) 1996-08-27 1996-08-27 Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
PCT/US1997/014863 WO1998008976A1 (en) 1996-08-27 1997-08-22 Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer

Publications (2)

Publication Number Publication Date
CA2264277A1 true CA2264277A1 (en) 1998-03-05
CA2264277C CA2264277C (en) 2008-04-15

Family

ID=24848902

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002264277A Expired - Fee Related CA2264277C (en) 1996-08-27 1997-08-22 Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer

Country Status (6)

Country Link
US (3) US5798266A (en)
EP (1) EP0932699A4 (en)
JP (1) JP2000514564A (en)
AU (1) AU740160B2 (en)
CA (1) CA2264277C (en)
WO (1) WO1998008976A1 (en)

Families Citing this family (162)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
AU1820100A (en) 1998-11-13 2000-06-05 Pro Duct Health, Inc. Devices and methods to identify ductal orifices during nipple aspiration
EP1495301A4 (en) * 1998-12-28 2005-04-13 Cytyc Corp Devices, methods and systems for collecting material from a breast duct
US6413228B1 (en) 1998-12-28 2002-07-02 Pro Duct Health, Inc. Devices, methods and systems for collecting material from a breast duct
WO2000043550A2 (en) * 1999-01-21 2000-07-27 Wayne State University Method and apparatus for measuring factors in mammary fluids
US6610484B1 (en) 1999-01-26 2003-08-26 Cytyc Health Corporation Identifying material from a breast duct
US6638727B1 (en) 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
GB9905817D0 (en) * 1999-03-12 1999-05-05 Oxford Glycosciences Uk Ltd Methods
EP1826569A1 (en) * 1999-05-17 2007-08-29 Cytyc Corporation Identifying material from a breast duct
US6642009B2 (en) * 1999-05-17 2003-11-04 Cytyc Health Corporation Isolated ductal fluid sample
US6964651B1 (en) 1999-06-23 2005-11-15 L. Jason Clute Apparatus for expressing milk
US6974439B1 (en) * 1999-06-23 2005-12-13 L. Jason Clute Apparatus for expressing milk
US7842458B2 (en) * 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
EP1208381A2 (en) * 1999-08-13 2002-05-29 Oxford GlycoSciences (UK) Limited Proteins, genes and their use for diagnosis and treatment of breast cancer
US6936424B1 (en) 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
US6894026B1 (en) 2000-01-11 2005-05-17 Atossa Healthcare, Inc. Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
AU2001229637A1 (en) * 2000-01-21 2001-07-31 Thomas Jefferson University Nipple aspirate fluid specific microarrays
US20030087265A1 (en) * 2000-01-21 2003-05-08 Edward Sauter Specific microarrays for breast cancer screening
DE10002803A1 (en) 2000-01-24 2001-08-02 Conbio Lizenzverwertungsgesell System for the internal qualitative and quantitative validation of marker indices
EP1280455A2 (en) * 2000-05-10 2003-02-05 Cytyc Health Corporation Method for differentiating breast ducts for cancer risk status
US6440100B1 (en) * 2000-05-31 2002-08-27 John Gilbert Prentiss Concealed apparatus for hands free breast milk pumping and storage
US20020037265A1 (en) * 2000-06-08 2002-03-28 David Hung Preparation for breast duct fluid collection
US6706012B2 (en) 2000-06-12 2004-03-16 L. Jason Clute Apparatus for expressing milk
JP2002112654A (en) * 2000-06-12 2002-04-16 Clute Lorne Jason Milking machine
DE10030827A1 (en) * 2000-06-23 2002-01-10 Univ Eberhard Karls Method for the detection of cathepsins, asparaginyl endopeptidase and their isozymes, and of leukocystatin
DE10050338A1 (en) * 2000-10-11 2002-04-25 Deutsches Krebsforsch Diagnosing and staging of cancer, especially of breast, by measuring levels of insulin receptor substrate-1 or insulin-like growth factor-1 receptor beta
WO2002038032A2 (en) * 2000-11-13 2002-05-16 Atossa Healthcare, Inc. Methods and devices for collecting and processing mammary fluid
US6585646B2 (en) 2000-11-29 2003-07-01 Hermetic Diagnostics, Inc. Screening test and procedure using skin patches
US20020117169A1 (en) 2001-02-27 2002-08-29 Kurz Daniel R. Cover and applicator for a portion of a mammalian body
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20070203802A1 (en) * 2005-09-23 2007-08-30 Prolacta Bioscience, Inc. Method for collecting, testing and distributing milk
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
AU2002308784B2 (en) * 2001-05-30 2008-04-17 Neomatrix, Llc. Noninvasive intraductal fluid diagnostic screen
SE0102922D0 (en) * 2001-08-31 2001-08-31 Astrazeneca Ab Method and apparatus for sample preparation
US6855554B2 (en) * 2001-09-21 2005-02-15 Board Of Regents, The University Of Texas Systems Methods and compositions for detection of breast cancer
US20030073930A1 (en) * 2001-10-17 2003-04-17 Morrissey Gerald R. Methods and device for preventing or healing injured nipples or areolas in mammalian females or for obtaining samples from nipples in mammalian females
DE10296200D2 (en) * 2001-12-21 2004-11-04 Biovision Ag Methods for diagnosing breast cancer, associated peptides and their uses
JP4579542B2 (en) 2001-12-27 2010-11-10 プレイテックス プロダクツ エルエルシー Milking cup
DE20120897U1 (en) * 2001-12-28 2003-05-08 Iws Ingenieurgesellschaft Wein Protective door for driver's cabins, especially for commercial vehicles
US7632650B2 (en) * 2002-01-09 2009-12-15 University Of Medicine And Dentistry Of New Jersey Diagnostics and therapeutic uses of topors
US7776524B2 (en) 2002-02-15 2010-08-17 Genzyme Corporation Methods for analysis of molecular events
US20090026122A1 (en) 2002-03-11 2009-01-29 Janusz Biocompatible solid-phase microextraction coatings and methods for their preparation
US9733234B2 (en) 2002-03-11 2017-08-15 Jp Scientific Limited Probe for extraction of molecules of interest from a sample
US7232689B2 (en) * 2002-03-11 2007-06-19 Pawliszyn Janusz B Calibration procedure for investigating biological systems
US8598325B2 (en) 2002-03-11 2013-12-03 Janusz B. Pawliszyn Solid-phase microextraction coatings and methods for their preparation
WO2003075772A2 (en) * 2002-03-11 2003-09-18 Pawliszyn Janusz B Micro-devices and analytical procedures for investigation of biological systems
US7259019B2 (en) * 2002-03-11 2007-08-21 Pawliszyn Janusz B Multiple sampling device and method for investigating biological systems
US9870907B2 (en) 2002-03-11 2018-01-16 Jp Scientific Limited Probe for extraction of molecules of interest from a sample
US7274809B2 (en) 2002-08-29 2007-09-25 Perceptronix Medical, Inc. And British Columbia Cancer Agency Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
JP2006502390A (en) * 2002-10-11 2006-01-19 センティナ バイオテクノロジー インコーポレイテッド Method for detection of breast cancer
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US7153691B2 (en) * 2002-11-13 2006-12-26 G6 Science Corp. Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
US20040097833A1 (en) * 2002-11-19 2004-05-20 Mueller, Richard L. Mammary fluid collection device and kit
US20040178162A1 (en) * 2003-03-14 2004-09-16 Dorothea Zucker-Franklin Devices and methods for removal of leukocytes from breast milk
CA2425350A1 (en) * 2003-04-14 2004-10-14 Peter Alex Container shut-off valve with venting
CA2523267C (en) 2003-04-23 2013-09-03 Biovalve Technologies, Inc. Hydraulically actuated pump for long duration medicament administration
US7828744B2 (en) * 2003-04-23 2010-11-09 Boston Scientific Scimed, Inc. Method and assembly for breast immobilization
EP2365001A3 (en) * 2003-05-01 2012-03-28 Imclone LLC Fully human antibodies directed against the human insulin-like growth factor-1 receptor
US7776008B2 (en) 2003-08-08 2010-08-17 Playtex Products, Inc. Manual breast pump
US7398054B2 (en) * 2003-08-29 2008-07-08 Zih Corp. Spatially selective UHF near field microstrip coupler device and RFID systems using device
US20060115383A1 (en) * 2003-09-16 2006-06-01 Vici Gig Harbor Group, Inc. Flow through well plate surface sorption extarction
US7087437B2 (en) * 2003-09-16 2006-08-08 Vici Gig Harbor Group, Inc. Direct vial surface sorbent micro extraction device and method
US20060110295A1 (en) * 2003-09-16 2006-05-25 Vici Gig Harbor Group, Inc. Closed well plate surface sorption extraction
US20060115384A1 (en) * 2003-09-16 2006-06-01 Vici Gig Harbor Group, Inc. Pipette tip surface sorption extraction
CA2441991C (en) * 2003-09-19 2012-11-13 Ronald R. Chisholm Fluid transfer apparatus
US20050115606A1 (en) * 2003-10-01 2005-06-02 Chisholm Ronald R. System for effecting liquid transfer from an elevated supply container
ATE534037T1 (en) * 2003-10-15 2011-12-15 Hoffmann La Roche USE OF THE PROTEIN ASC AS A MARKER FOR BREAST CANCER
GB0325129D0 (en) 2003-10-28 2003-12-03 Smith & Nephew Apparatus in situ
GB0325126D0 (en) 2003-10-28 2003-12-03 Smith & Nephew Apparatus with heat
JP4912894B2 (en) 2004-02-19 2012-04-11 イェール ユニバーシティー Identification of oncoprotein biomarkers using proteomic technology
US8100887B2 (en) 2004-03-09 2012-01-24 Bluesky Medical Group Incorporated Enclosure-based reduced pressure treatment system
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US7708724B2 (en) 2004-04-05 2010-05-04 Blue Sky Medical Group Incorporated Reduced pressure wound cupping treatment system
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US7776028B2 (en) 2004-04-05 2010-08-17 Bluesky Medical Group Incorporated Adjustable overlay reduced pressure wound treatment system
US7998125B2 (en) 2004-05-21 2011-08-16 Bluesky Medical Group Incorporated Hypobaric chamber treatment system
WO2005113835A2 (en) * 2004-05-21 2005-12-01 Northeastern University Kits and methods for indentification, assessment, prevention and therapy of breast cancer
WO2005124360A2 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein tebp as a marker for breast cancer
WO2005123944A1 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein pdx1 as a marker for breast cancer
WO2006014425A1 (en) 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Methods and devices for delivering glp-1 and uses thereof
WO2006026654A2 (en) 2004-08-27 2006-03-09 Exact Sciences Corporation Method for detecting a recombinant event
WO2006034278A2 (en) * 2004-09-21 2006-03-30 Matritech, Inc. Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
AU2005289756B2 (en) * 2004-09-22 2011-10-13 Tripath Imaging, Inc. Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
US7559915B2 (en) * 2004-10-13 2009-07-14 Stella Dao Breast pump device with self-contained breast milk reservoir
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US7648467B2 (en) * 2004-12-08 2010-01-19 Wang Paul C Device for non-surgical correction of congenital inverted nipples and/or collection of nipple aspirate fluid
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
JP2008541051A (en) * 2005-05-02 2008-11-20 ザ・キュレーターズ・オブ・ザ・ユニバーシティ・オブ・ミズーリ Carbohydrate biomarker detection
US20060252685A1 (en) * 2005-05-04 2006-11-09 Gould Jeffrey D Treatment for sleep apnea
ES2452115T3 (en) 2005-06-17 2014-03-31 Imclone Llc An anti-PDGFRalpha antibody for use in the treatment of metastatic bone cancer
CA2923372C (en) 2005-09-07 2019-07-30 Smith & Nephew, Inc. Self contained wound dressing apparatus
JP2009506878A (en) 2005-09-07 2009-02-19 タイコ ヘルスケア グループ リミテッド パートナーシップ Self-contained wound care with micropump
WO2007035870A2 (en) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
CN100350244C (en) * 2005-10-19 2007-11-21 大连轻工业学院 Thin-layer chromatography assay method for Fumonisins B1
US8532938B2 (en) 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8068991B2 (en) 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US7827042B2 (en) 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
AT9121U1 (en) * 2006-01-24 2007-05-15 Mam Babyartikel SUPPLEMENT FOR A MILK PUMP
JP5198289B2 (en) * 2006-02-03 2013-05-15 イムクローン・リミテッド・ライアビリティ・カンパニー IGF-IR antagonists as adjuvants for the treatment of prostate cancer
US20070243561A1 (en) * 2006-02-16 2007-10-18 Ben Geeraerts Prognostic markers in chronic lymphocytic leukemia
CN103239773B (en) 2006-03-30 2015-08-26 瓦莱里塔斯公司 Multi-cartridge fluid delivery device
US7806855B2 (en) 2006-04-11 2010-10-05 Playtex Products, Inc. Manual breast pump
US8078260B2 (en) * 2006-05-02 2011-12-13 ORGAMEND Inc. Method for improving magnetic resonance imaging of the breast
US7779625B2 (en) 2006-05-11 2010-08-24 Kalypto Medical, Inc. Device and method for wound therapy
US20080153110A1 (en) * 2006-10-25 2008-06-26 Tim Scherkenback Combination Rapid Detection Cartridges For Biological and Environmental Agents, Methods of Production and Uses Thereof
EP3485742B1 (en) * 2006-11-29 2021-09-01 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
US8377445B2 (en) * 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
US7803134B2 (en) * 2007-01-10 2010-09-28 Animas Corporation Syringe assembly and infusion pump assembly incorporating such
US20100256464A1 (en) * 2007-05-14 2010-10-07 Dr. Susan Love Research Foundation Device for determining risk of developing breast cancer and method thereof
US8652022B2 (en) * 2007-09-10 2014-02-18 Boston Scientific Scimed, Inc. Stabilizer and method for irradiating tumors
EP3360519B1 (en) 2007-11-21 2020-11-18 Smith & Nephew plc Wound dressing
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
MX2010005553A (en) 2007-11-21 2010-06-01 Smith & Nephew Wound dressing.
US20100036367A1 (en) * 2008-08-05 2010-02-11 Bluesky Medical Group, Inc. Wound overlay with cuff for wound treatment employing reduced pressure
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US7972297B2 (en) * 2008-11-07 2011-07-05 Simplisse, Inc. Breast cup assembly for a breast pump
JP2012510476A (en) 2008-12-02 2012-05-10 プロラクタ バイオサイエンス，インコーポレイテッド Human milk permeation composition and methods of making and using
EP2419157A4 (en) 2009-04-17 2018-01-03 Kalypto Medical, Inc. Negative pressure wound therapy device
US8469770B2 (en) 2009-10-20 2013-06-25 Dawn Michele Alva Multifunction brassiere cup
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
KR101313184B1 (en) * 2010-06-24 2013-09-30 한국표준과학연구원 Disease Marker Detection Kit and the Detection Method of Disease Marker
US20170150857A1 (en) * 2010-12-31 2017-06-01 Del Lathim Hand-operable vacuum device
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US10853819B2 (en) 2011-04-14 2020-12-01 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US9058634B2 (en) 2011-05-24 2015-06-16 Kalypto Medical, Inc. Method for providing a negative pressure wound therapy pump device
WO2012161723A1 (en) 2011-05-24 2012-11-29 Kalypto Medical, Inc. Device with controller and pump modules for providing negative pressure for wound therapy
US9067003B2 (en) 2011-05-26 2015-06-30 Kalypto Medical, Inc. Method for providing negative pressure to a negative pressure wound therapy bandage
DK2739157T3 (en) 2011-08-03 2018-01-08 Prolacta Bioscience Inc Microfiltration of human milk to reduce bacterial contamination
CA2853351A1 (en) * 2011-10-24 2013-05-02 Atossa Genetics, Inc. Method of breast cancer detection
US20130130310A1 (en) * 2011-10-24 2013-05-23 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection
CN102520097B (en) * 2011-12-26 2014-03-26 上海仪电分析仪器有限公司 Zero air generator
US9155339B2 (en) 2013-02-04 2015-10-13 Dawn Michele Alva Garments for a nursing woman
WO2014158911A1 (en) 2013-03-13 2014-10-02 Prolacta Bioscience High fat human milk products
JP2017529199A (en) 2014-08-12 2017-10-05 ネクストジェン ジェイン， インコーポレイテッド System and method for monitoring health based on collected body fluid
RU2017127734A (en) 2015-01-07 2019-02-07 Трайджемина, Инк. MAGNESIUM-CONTAINING COMPOSITIONS OF OXYTOCINE AND METHODS OF APPLICATION
US9919084B2 (en) 2015-04-14 2018-03-20 Ashia M. Pollen Vacuum break backflow preventer for breast pump systems
US10016547B2 (en) 2015-04-14 2018-07-10 Ashia M. Pollen Foolproof valve assembly for a breast milk collector
US10039871B2 (en) 2015-04-14 2018-08-07 Ashia M. Pollen Milk repellent breast pump
SG11201805635RA (en) 2015-12-30 2018-07-30 Prolacta Bioscience Inc Human milk products useful in pre- and post-operative care
EP3423186A4 (en) 2016-03-02 2019-10-23 JP Scientific Limited Solid phase microextraction coating
MX2018012351A (en) * 2016-04-12 2019-02-07 Trigemina Inc Magnesium-containing oxytocin formulations and methods of use.
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods
JP6803400B2 (en) 2016-05-10 2020-12-23 ジェイ・ピィ・サイエンティフィック・リミテッドＪｐ Ｓｃｉｅｎｔｉｆｉｃ Ｌｉｍｉｔｅｄ Systems and methods for desorbing and detecting analytes adsorbed on solid-phase microextractors
US10238153B2 (en) 2016-06-29 2019-03-26 Rumina Nursingwear Garments for a nursing woman
US11241048B2 (en) 2016-10-17 2022-02-08 Rumina Nursingwear Garments for nursing or for hands-free use of a breast pump
CN110286166A (en) * 2019-06-11 2019-09-27 江西师范大学 A kind of method of quick detection protein isomer
US20210139833A1 (en) * 2019-11-07 2021-05-13 Rutgers, The State University Of New Jersey Multilayer stackable tissue culture platform for 3d co-culture

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH408930A (en) * 1962-01-26 1966-03-15 Sandoz Ag Process for the production of a previously unknown polypeptide
US3786801A (en) 1969-02-24 1974-01-22 Diagnostic Inc Method and apparatus for aiding in the detection of breast cancer
CS194980B1 (en) * 1976-07-16 1979-12-31 Joseph H Cort Agent for current induction,fertilization facilitating and milkability increasing at mammals,especially at utility cattle
US4263912A (en) * 1977-06-08 1981-04-28 Adams Frank H Milking apparatus and method
US4147514A (en) 1977-11-21 1979-04-03 Miles Laboratories, Inc. Test means and method for detecting ketone bodies
US4857051A (en) * 1980-09-05 1989-08-15 Isg/Ag Breastpump
US4680028A (en) * 1984-07-02 1987-07-14 Lact-Assist, Incorporated Flexible breast receptor for breast pump
JPS6294170A (en) * 1985-10-21 1987-04-30 ピジヨン株式会社 Milking device
US5007899A (en) * 1988-02-29 1991-04-16 Isg/Ag Drive unit adapted for use with manual piston pump
US4929229A (en) 1988-11-30 1990-05-29 Isg/Ag Breastpump having improved valve mechanism
EP0394510A1 (en) * 1989-04-24 1990-10-31 Mochida Pharmaceutical Co., Ltd. Method for assaying a tumor-associated antigen in a minute amount of nipple discharge and device for such an assay
US5295957A (en) * 1991-12-23 1994-03-22 Pigeon Co., Ltd. Breast pump having a pressure adjusting mechanism
US5601531A (en) 1995-02-16 1997-02-11 Medela, Incorporated Breast pump assembly and method of using same
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US6110140A (en) * 1996-09-17 2000-08-29 Medela, Inc. Manual breastmilk pump
WO1999021964A1 (en) * 1997-10-24 1999-05-06 Georgetown University Evaluation of changes in breast cells using nipple aspirate fluid

Also Published As

Publication number Publication date
EP0932699A4 (en) 2004-05-06
WO1998008976A1 (en) 1998-03-05
EP0932699A1 (en) 1999-08-04
JP2000514564A (en) 2000-10-31
AU4085097A (en) 1998-03-19
US5798266A (en) 1998-08-25
US7128877B2 (en) 2006-10-31
CA2264277C (en) 2008-04-15
US20030219812A1 (en) 2003-11-27
AU740160B2 (en) 2001-11-01
US6287521B1 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
CA2264277A1 (en) Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
AU2716302A (en) Methods and devices for collecting, handling and processing mammary fluid samples for evaluating breast diseases, including cancer
Ceriani et al. Circulating human mammary epithelial antigens in breast cancer.
Kerjaschki et al. Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells.
CA2224970A1 (en) Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantation
CA2140908A1 (en) Method of recovering endothelial membrane from tissue and applications thereof
Patterson et al. Monoclonal antibody 4F2 reactive with basal layer keratinocytes: studies in the normal and a hyperproliferative state
Favrot et al. Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies
Furmanski et al. Brief Communication: Normal Human Mammary Cells in Culture: Evidence for OncornavirusMLike Particles
Galili et al. Human prothymocytes. Membrane properties, differentiation patterns, glucocorticoid sensitivity, and ultrastructural features.
ES8501630A1 (en) In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins.
Barnes et al. Glass-bead affinity chromatography of cell attachment and spreading-promoting factors of human serum
Pinkus et al. Antigenic separation of a nonkinin-generating TAMe esterase from human urinary kallikrein and immunohistochemical comparison of their localization in the kidney.
CN109490556B (en) Application of AGP1, ORM2 and C9 in distinguishing tuberculous pleural effusion from malignant pleural effusion
CN109852721A (en) Detect biomarker, application and the detection method of chornic arthritis disease
Higgins et al. Expression of gastric-associated antigens by human premalignant and malignant colonic epithelial cells
Børjesson et al. Estradiol receptors in subpopulations of breast cancer cells isolated from human primary tumors
US5164489A (en) Lung growth stimulatory and inhibitory factors for carcinoma tumor cells
Tapper et al. Identification of a unique biological tumor marker in human breast cyst fluid and breast cancer tissue
Wang et al. Subclinical metastasis of uveal melanoma
Matsumoto et al. Angiogenesis in metastatic verrucous carcinoma of the uterine cervix.
Gustavii et al. Trophoblast samples suitable for long-term culture
鈴木雅実 et al. Application of complement-dependent antibody cytotoxicity test for diagnosis of enzootic bovine lymphosarcoma.
RU2232397C2 (en) Method for early diagnosis of pathological state of endometrium
Masood Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170822